Ingredient shelf life is not finished-product shelf life
The storage conditions and shelf life declared for an ingredient relate to its defined product and packaging conditions. They cannot simply be assigned to a new liquid mixture, sachet or capsule. Appropriate stability assessment should consider the finished composition, manufacturing process and package.
A 2024 liposomal vitamin C manufacturing study illustrates the assessment of processing parameters alongside the resulting structure. Such development results should not be treated as ready-made operating instructions for another manufacturer or formulation.
Source: FDA (2018) — Liposome Drug Products; technical framework for process and stability; Romano et al. (2024) — Liposomal vitamin C manufacturing and stability research
Conditions to clarify before manufacture
| Topic | Development question |
|---|---|
| Temperature and duration | At what stage, and for how long, will the ingredient encounter heat? |
| pH and other components | Are the intended medium, salts and excipients compatible with the carrier? |
| Mixing and processing | Does the proposed process match the manufacturer’s recommended conditions? |
| Moisture and oxygen | Which exposures need to be managed during manufacture and storage? |
| Filling and packaging | Is the selected material suitable for the product and intended use period? |
Source: FDA (2018) — Liposome Drug Products; technical framework for process and stability
A liquid product requires more than an appearance check
A 2015 study of liposomal components in orange juice illustrates the joint assessment of heat treatment, composition and sensory properties. Its findings do not demonstrate identical heat tolerance for all liposomal ingredients.
Sample work can track appearance, taste and odour, usability and measurable quality parameters within one plan. An ingredient that appears suitable on its own still needs assessment in the intended final mixture.
Source: Marsanasco et al. (2015) — Liposomal components assessed in an orange juice matrix
Do not leave packaging until the end
Requirements concerning moisture, light and oxygen depend on product characteristics. There is no single bottle, sachet or storage condition suitable for every liposomal product. Packaging selection should progress alongside manufacturer data and finished-product evaluation.
Use after opening for liquids, repeated opening for powders and shipping conditions may also be relevant to the plan. Label storage instructions should be consistent with the available evidence.
Source: FDA (2018) — Liposome Drug Products; technical framework for process and stability
Planning pilot work with Biontera
Sharing the target format, production flow and packaging options early makes ingredient assessment more practical. We can review the dossier and sample together to establish the topics that development needs to address.
- Review the ingredient specification and manufacturer’s conditions of use.
- Prepare the intended formula at laboratory or pilot scale.
- Identify suitable chemical, physical and microbiological quality parameters.
- Assess the finished product in the selected packaging and storage conditions.
- Revisit changed process conditions when moving to manufacturing scale.